Past Meetings

Presentations reflect personal opinions of their respective authors. Reference herein to any specific commercial product or company does not constitute its endorsement, recommendation, or favoring by the U. S. Government, NIH or any of their employees or contractors.  Please, read complete Disclaimer.

• Moving from the Bench Into Business: Entrepreneurship in Science
  Conference, April 18, 2002
• Venture Capital
  Wei-Wu He, 11/12/02
• Dealing with Industry from within NIH
  Francis Collins, 02/25/03
  
• An Anatomy of a Deal
  Jerry Feigen, March 13, 2003
• How can the NIH better interact with BIO 2003?
  Ray Briscuso, Executive Director, BIO, 03/21/03
• Incubators
  Ed Sybert, Director of the Technology Advancement Program, University of Maryland 
  03/27/03
  
• Tour of the Shady Grove Incubator
  April 15th, 2003
• The Real World of Investment Banking and Raising Capital for Emerging Bio Firms
  Gordon Macklin, 04/24/03
• Biotechnology Industry Organization 2003 Annual Convention
  Washington Convention Center, June 21-25, 2003
• Raising funds - a real life example
  Lou Cantolupo, Aug. 19, 2003
• Patents
  Mark Nuell
  September 3, 2003
• Turning Scientists and Technologists into Managers
  Andrés G. Fortino, Sep 10, 2003
• Funding the Transfer of Technology from Public Laboratories
  Steve Fritz, Sep 24, 2003
• Starting the company: doing it old-fashioned way
  Ilya Mazo, Oct 22, 2003
• An Industry Guide to Partnering
  Thomas Stackhouse, Ph.D. - Associate Chief for Frederick Operations, Technology Transfer Branch, NCI - December 9, 2003.
• Tony Heher
  Friday, 12 December at 2:00 Bldg. 37 Room 4146A
• What You Need Beyond Great Science: Lessons for Entrepreneurs
  Wednesday, January 14th, at 12:00 Bldg. 37,  4th floor conference room.
  Christine D. Copple, Ph.D. - President and CEO of ASMR - the for-profit Venture arm of the American Society for Microbiology
• Biotech's Worldwide Overview (Circa 2004)
  Wednesday, January 21, 2004, 4:30-5:30pm Bldg. 31, Room 6C6
  G. Steven Burrill, CEO, Burrill & Co. shared his vision of Biotech industry.
  
• Between The Bench, The Bed and The Marketplace
  Wednesday, February 25th, 12:00 - 1:00 pm Bldg. 37, 4th floor conference room
  Michael A. Zasloff, M.D., Ph.D, Dean of Research and Translational Science, Georgetown University
  
• MedImmune Oncology Pipeline and Clinical Trials
  Wednesday, March 31. 2004, 12:00-1:00 pm, NIH, Bethesda, Bldg 37, 4-th floor Conference Room
  Dr. Isagani Chico, Head of Medical Affairs Oncology at MedImmune, Inc.
• So, you want to start a biotech company?
  Wednesday, October 20th, 2004. 12:00-1:00 pm, NIH, Bethesda, Bldg 37, 4-th floor Conference Room
  John Holaday, co-founder and Chairman of HarVest Bank of Maryland
• Wednesday, November 10th, 2004, at 12:00, Bldg. 37,  4th floor conference room (4041/4107) . A Personal Story of Starting, Surviving, and Enjoying a Life Sciences Business, Shira Kramer, President and Founder of the Sterilex Corporation.
• Meeting the Challenges by Grabbing the Opportunities 

  Wednesday, January 26th, 2005. 12:00-1:00 pm, NIH, Bethesda, Bldg 37, 4-th floor Conference Room

  Yiqing Liang, PhD, Founder, President and CEO, Clever Sys. Inc.
• Entrepreneurial Skills and Opportunities Workshop. John Holaday, Ph.D., Montgomery Pacific Group and EntreMed Founder; Shira Kramer, Ph.D., President, Sterilex Corporation; Tania Fernandez, Ph.D., Analyst, Burrill and Company; Moderator: Val Bliskovsky. February 28, 2006, Clarion Fontainebleau Hotel, 10100 Coastal Highway, Ocean City, Maryland 21842
• "A New Organization Supporting Bioscience in Maryland"
  Robert Eaton, President, MdBio
  Wednesday, May 10, 2006, 12:00-1:00 pm, NIH, Bethesda, Bldg 37, 4-th floor Conference Room (4041/4107)
• “Quantitative Pathology & Companion Diagnostics: Approaching the Realization of Personalized Medicine”
  Robert A. Curtis, PharmD
  President & CEO
  HistoRx, Inc.
  Wednesday, May 24, 2006, 12:00-1:00 pm, NIH, Bethesda, Bldg 37, 4-th floor Conference Room (4041/4107)
• "Adventures in Biotechnology: A scientist's perspective on starting and growing biotech companies."
  Boro Dropulic, Ph.D. M.B.A
  Founder & CEO
  Lentigen Corporation
  Wednesday, January 16, 2008, 12:00-1:00 pm, NIH, Bethesda, Bldg 37, 4-th floor Conference Room (4041/4107)
• “Serotonin is required absolutely by dividing lymphocytes.” Stephen Roth, Ph.D., President & CEO
  David Zopf, M.D., Chief Scientific Officer, Immune Control, Inc. Wednesday, April 2, 2008, 12:00-1:00 pm, NIH, Bethesda, Bldg 37, 4-th floor Conference Room (4041/4107) Abstract